Trademark Overview
On Friday, March 29, 2024, a trademark application was filed for XAIRA with the United States Patent and Trademark Office. The USPTO has given the XAIRA trademark a serial number of 98476104. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, March 30, 2024. This trademark is owned by Orion Medicines, Inc.. The XAIRA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical therapeutics, pharmaceutical preparations, medical therapeutics, and medical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology
Pharmaceutical research and development services; Scientific and medical research in the field of pharmaceutical development; Artificial intelligence, machine learning, and related services for life sciences and pharmaceutical development; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Biomedical research and development services; Pharmaceutical research and development services, namely, arranging and providing for clinical trials